TY - JOUR
AU - V Perkovic
BT - Circulation
PY - 2019
SP - 739 
EP -  750
T2 - Circulation
TI - Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups
VL - 140
ER -